424
Participants
Start Date
December 31, 2016
Primary Completion Date
February 28, 2019
Study Completion Date
May 31, 2019
Xpert Bladder Cancer Monitor
in vitro diagnostic test for the recurrence of bladder cancer in patients that have been previously diagnosed with bladder cancer
Virginia Urology, Richmond
Five Valleys Urology, Missoula
UroPartners, Melrose Park
Stephenson Cancer Center, Oklahoma City
UT Southwestern, Dallas
Urology Associates, P.C., Englewood
The Urology Center of Colorado, P.C., Denver
Idaho Urologic Institute, Meridian
North Idaho Urology, Coeur d'Alene
PAVA, Palo Alto
Weill Cornell Medicine, New York
The Male/Female Health and Research Centre, Barrie
G Kenneth Jansz Medicine Professional Corp., Burlington
Urology Associates / Urologic Medical Research, Kitchener
Urology Clinic of Dr. Goldfarb, North Bay
Urologic Clinic of Stanley Flax, North York
Radboud University Medical Center, Nijmegen
Lead Sponsor
Cepheid
INDUSTRY